Stocks To Watch: Reliance Industries, Ambuja Cements, Dr Reddy’s Laboratories

0
37


Reliance Industries will declare its March quarter earnings put up market hours.

The home inventory markets are more likely to open within the unfavorable, after 4 successive days of good points, going by early indications from SGX Nifty futures buying and selling. Trends on SGX Nifty point out a unfavorable begin for the Nifty in India, with a lack of 190.50 factors or 1.28 per cent. At 8:00 am, the Nifty futures have been buying and selling at 14,740.50,weaker by 190.50 factors or 1.28 per cent on the Singapore Stock Exchange.

The benchmark indices ended mildly within the constructive on Thursday, making it 4 successive days of good points, amid heightened volatility. The Sensex ended the session at 49,765.94, larger by 32.10 factors or 0.06 per cent and the Nifty closed at 14,894.90, up 30.35 factors or 0.20 per cent.

Stocks to look at in commerce in as we speak’s session

Reliance Industries

Reliance Industries will declare its This autumn earnings put up market hours.

Ambuja Cements

Ambuja Cements reported a pointy rise in standalone revenue at Rs 664.6 crore within the quarter ended March 2021 as towards Rs 399 crore within the corresponding quarter final yr, whereas revenues jumped from Rs 2,827,5 crore to Rs 3,621.4 crore.

Dr Reddy’s Laboratories

Dr Reddy’s Laboratories introduced the launch of Albendazole tablets within the US market. It is a therapeutic equal generic model of Albenza tablets.

Titan Company

Titan Company’s standalone earnings rose to Rs 529 crore in Q4FY21 from Rs 357 crore in Q4FY20, whereas revenues spiked to Rs 7,135 crore from Rs 4,429 crore.



Source hyperlink